Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8604183
APP PUB NO 20050026160A1
SERIAL NO

10701007

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions comprising at least one oligomeric compound comprising an alternating motif and further include a region that is complementary to a nucleic acid target. The compositions are useful for targeting selected nucleic acid molecules and modulating the expression of one or more genes. In preferred embodiments the compositions of the present invention hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA. The present invention also provides methods for modulating gene expression.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • IONIS PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allerson, Charles Carlsbad, US 49 2504
Baker, Brenda F Carlsbad, US 129 3785
Bhat, Balkrishen Carlsbad, US 172 7007
Eldrup, Anne B Ridgefield, US 45 3057
Griffey, Richard H Vista, US 162 5635
Manoharan, Muthiah Weston, US 474 16991
Swayze, Eric E Carlsbad, US 344 9246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00